Search Results

There are 24438 results for: content related to: Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis

  1. Infliximab for the treatment of rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Barbara BTB Blumenauer, Maria Judd, George A Wells, Amanda Burls, Ann Cranney, Marc C Hochberg, Peter Tugwell and Maria Angeles Lopez-Olivo

    Published Online : 22 JUL 2002, DOI: 10.1002/14651858.CD003785

  2. You have free access to this content
    The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 46, Issue 6, June 2002, Pages: 1451–1459, E. William St.Clair, Carrie L. Wagner, Adedigbo A. Fasanmade, Benjamin Wang, Thomas Schaible, Arthur Kavanaugh and Edward C. Keystone

    Version of Record online : 6 JUN 2002, DOI: 10.1002/art.10302

  3. You have free access to this content
    Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: Results from a randomized control study

    Arthritis Care & Research

    Volume 61, Issue 5, 15 May 2009, Pages: 569–576, Roman Krzysiek, Maxime Breban, Philippe Ravaud, Maria Vittoria Prejean, John Wijdenes, Carine Roy, Yves-Dominique Henry, Carole Barbey, Gérard Trappe, Maxime Dougados and Dominique Emilie

    Version of Record online : 29 APR 2009, DOI: 10.1002/art.24275

  4. You have free access to this content
    A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis

    Arthritis & Rheumatism

    Volume 56, Issue 9, September 2007, Pages: 3096–3106, Nicolino Ruperto, Daniel J. Lovell, Ruben Cuttica, Nick Wilkinson, Patricia Woo, Graciela Espada, Carine Wouters, Earl D. Silverman, Zsolt Balogh, Michael Henrickson, Maria-Teresa Apaz, Eileen Baildam, Anders Fasth, Valeria Gerloni, Pekka Lahdenne, Anne-Marie Prieur, Angelo Ravelli, Rotraud K. Saurenmann, Maria Luz Gamir, Nico Wulffraat, Laszlo Marodi, Ross E. Petty, Rik Joos, Francesco Zulian, Deborah McCurdy, Barry L. Myones, Kalman Nagy, Peter Reuman, Ilona Szer, Suzanne Travers, Anna Beutler, Greg Keenan, Jason Clark, Sudha Visvanathan, Adedigbo Fasanmade, Aparna Raychaudhuri, Alan Mendelsohn, Alberto Martini and Edward H. Giannini

    Version of Record online : 30 AUG 2007, DOI: 10.1002/art.22838

  5. You have free access to this content
    Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

    Arthritis & Rheumatism

    Volume 50, Issue 11, November 2004, Pages: 3432–3443, E. William St. Clair, Désirée M. F. M. van der Heijde, Josef S. Smolen, Ravinder N. Maini, Joan M. Bathon, Paul Emery, Edward Keystone, Michael Schiff, Joachim R. Kalden, Ben Wang, Kimberly DeWoody, Roberta Weiss, Daniel Baker and Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group

    Version of Record online : 4 NOV 2004, DOI: 10.1002/art.20568

  6. You have free access to this content
    TNF-alpha inhibitors for ankylosing spondylitis

    Intervention Review

    The Cochrane Library

    Lara J Maxwell, Jane Zochling, Annelies Boonen, Jasvinder A Singh, Mirella MS Veras, Elizabeth Tanjong Ghogomu, Maria Benkhalti Jandu, Peter Tugwell and George A Wells

    Published Online : 18 APR 2015, DOI: 10.1002/14651858.CD005468.pub2

  7. You have free access to this content
    Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials

    Alimentary Pharmacology & Therapeutics

    Volume 30, Issue 3, August 2009, Pages: 210–226, G. R. LICHTENSTEIN, R. H. DIAMOND, C. L. WAGNER, A. A. FASANMADE, A. D. OLSON, C. W. MARANO, J. JOHANNS, Y. LANG and W. J. SANDBORN

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1365-2036.2009.04027.x

  8. Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 7, July 2012, Pages: 1199–1206, Benjamin Pariente, Guillaume Pineton de Chambrun, Roman Krzysiek, Marine Desroches, Gauthier Louis, Chiara De Cassan, Clotilde Baudry, Jean-Marc Gornet, Pierre Desreumaux, Dominique Emilie, Jean-Frédéric Colombel and Matthieu Allez

    Version of Record online : 29 AUG 2011, DOI: 10.1002/ibd.21839

  9. You have free access to this content
    Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: An open, observational, extension study of a three-month, randomized, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 48, Issue 8, August 2003, Pages: 2224–2233, J. Braun, J. Brandt, J. Listing, A. Zink, R. Alten, G. Burmester, W. Golder, E. Gromnica-Ihle, H. Kellner, M. Schneider, H. Sörensen, H. Zeidler, J. Reddig and J. Sieper

    Version of Record online : 1 AUG 2003, DOI: 10.1002/art.11104

  10. You have free access to this content
    Perioperative Infliximab Application Ameliorates Acute Rejection Associated Inflammation After Intestinal Transplantation

    American Journal of Transplantation

    Volume 10, Issue 11, November 2010, Pages: 2431–2441, T. Pech, T. Finger, J. Fujishiro, M. Praktiknjo, I. Ohsawa, K. Abu-Elmagd, A. Limmer, A. Hirner, J. C. Kalff and N. Schaefer

    Version of Record online : 26 OCT 2010, DOI: 10.1111/j.1600-6143.2010.03279.x

  11. You have free access to this content
    Practical application of anti-TNF therapy for luminal Crohn's disease

    Inflammatory Bowel Diseases

    Volume 17, Issue 11, November 2011, Pages: 2366–2391, Michael A. Kamm, Siew C. Ng, Peter De Cruz, Patrick Allen and Stephen B. Hanauer

    Version of Record online : 18 FEB 2011, DOI: 10.1002/ibd.21655

  12. You have free access to this content
    Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 118–128, David Ternant, Emilie Ducourau, Aleth Perdriger, Anca Corondan, Benoît Le Goff, Valérie Devauchelle-Pensec, Elisabeth Solau-Gervais, Hervé Watier, Philippe Goupille, Gilles Paintaud and Denis Mulleman

    Version of Record online : 20 JUN 2014, DOI: 10.1111/bcp.12313

  13. Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience

    Alimentary Pharmacology & Therapeutics

    Volume 44, Issue 7, October 2016, Pages: 673–683, T. Billiet, I. Cleynen, V. Ballet, M. Ferrante, G. Van Assche, A. Gils and S. Vermeire

    Version of Record online : 9 AUG 2016, DOI: 10.1111/apt.13754

  14. You have free access to this content
    Tumor Necrosis Factor Alpha Inhibitors as Immunomodulatory Antirejection Agents after Intestinal Transplantation

    American Journal of Transplantation

    Volume 11, Issue 5, May 2011, Pages: 1041–1050, U. A. Gerlach, M. Koch, H.-P. Müller, W. Veltzke-Schlieker, P. Neuhaus and A. Pascher

    Version of Record online : 26 APR 2011, DOI: 10.1111/j.1600-6143.2011.03497.x

  15. You have free access to this content
    Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: A detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study

    Arthritis & Rheumatism

    Volume 52, Issue 4, April 2005, Pages: 1020–1030, J. S. Smolen, C. Han, M. Bala, R. N. Maini, J. R. Kalden, D. van der Heijde, F. C. Breedveld, D. E. Furst, P. E. Lipsky and ATTRACT Study Group

    Version of Record online : 7 APR 2005, DOI: 10.1002/art.20982

  16. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease

    Intervention Review

    The Cochrane Library

    Brian W Behm and Stephen J Bickston

    Published Online : 23 JAN 2008, DOI: 10.1002/14651858.CD006893

  17. Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 8, August 2011, Pages: 838–848, John Paul Leombruno, Geoffrey C. Nguyen, Paul Grootendorst, David Juurlink and Tom Einarson

    Version of Record online : 17 JUN 2011, DOI: 10.1002/pds.2132

  18. You have free access to this content
    Costs of care for Crohn’s disease following the introduction of infliximab: a single-centre UK experience

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 11-12, December 2010, Pages: 1357–1363, M. B. Sprakes, A. C. Ford, N. C. Suares, L. Warren, D. Greer, C. F. Donnellan, J. S. R. Jennings, S. M. Everett and P. J. Hamlin

    Version of Record online : 6 OCT 2010, DOI: 10.1111/j.1365-2036.2010.04482.x

  19. Infliximab dependency in pediatric Crohn's disease: Long-term follow-up of an unselected cohort

    Inflammatory Bowel Diseases

    Volume 14, Issue 3, March 2008, Pages: 353–358, Lissy de Ridder, Edmond H.H.M. Rings, Gerard M. Damen, C.M. Frank Kneepkens, Joachim J. Schweizer, Freddy T.M. Kokke, Marc A. Benninga, Obbe F. Norbruis, J. Hans Hoekstra, Carolien F.M. Gijsbers and Johanna C. Escher

    Version of Record online : 10 DEC 2007, DOI: 10.1002/ibd.20329

  20. Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn's disease

    Inflammatory Bowel Diseases

    Volume 10, Issue 6, November 2004, Pages: 801–810, Mihaela Ringheanu, Fredric Daum, James Markowitz, Jeremiah Levine, Seymour Katz, Xingyu Lin and Jack Silver

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200411000-00015